Related Experiment Videos

High frequency and heterogeneous distribution of p53 mutations in aflatoxin B1-induced mouse lung tumors

A S Tam1, J F Foley, T R Devereux

  • 1Department of Pharmacology and Toxicology, Queen's University, Kingston, Ontario, Canada.

Cancer Research
|August 14, 1999
PubMed

Insights

Aflatoxin B1 (AFB1) induced p53 gene mutations in mouse lung tumors, with mutations often occurring late in tumorigenesis. Laser capture microdissection improved detection of these p53 alterations.

Area of Science:

  • Oncology
  • Genetics
  • Toxicology

Background:

  • Inactivation of the p53 tumor suppressor gene is common in human lung cancers.
  • p53 mutations are less frequently detected in chemically induced mouse lung tumors.

Purpose of the Study:

  • To investigate p53 alterations in aflatoxin B1 (AFB1)-induced mouse lung tumors.
  • To compare the efficacy of different methods for detecting p53 mutations in these tumors.

Main Methods:

  • 62 female AC3F1 mice were treated with AFB1.
  • 71 induced lung tumors were analyzed for p53 protein overexpression via immunohistochemistry.
  • p53 gene mutations were assessed using single-strand conformational polymorphism (SSCP) and direct sequencing on whole tumor DNA and laser capture microdissected (LCM) cells.

Main Results:

  • 79% of AFB1-induced tumors showed p53 protein overexpression, often heterogeneously.
  • SSCP analysis of whole tumors detected mutations in 26% of samples, primarily in exons 6 and 7.
  • LCM followed by sequencing identified mutations in 60% of samples, revealing various mutation types and a 72% concordance with immunostaining, compared to 17% for whole tumor analysis.

Conclusions:

  • p53 mutations occur relatively late in AFB1-induced mouse lung tumorigenesis.
  • LCM significantly enhances the detection of p53 alterations in heterogeneous tumor samples.
  • These findings highlight the importance of analyzing specific regions within tumors for accurate molecular profiling.

Related Concept Videos